- Previous Close
73.06 - Open
73.00 - Bid 28.92 x 1100
- Ask 115.08 x 800
- Day's Range
71.11 - 73.59 - 52 Week Range
71.11 - 113.63 - Volume
86,528 - Avg. Volume
105,596 - Market Cap (intraday)
1.093B - Beta (5Y Monthly) 1.51
- PE Ratio (TTM)
39.09 - EPS (TTM)
1.84 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield 1.80 (2.50%)
- Ex-Dividend Date Mar 14, 2025
- 1y Target Est
108.33
U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
www.usph.com4,034
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: USPH
View MorePerformance Overview: USPH
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USPH
View MoreValuation Measures
Market Cap
1.09B
Enterprise Value
1.35B
Trailing P/E
39.09
Forward P/E
29.94
PEG Ratio (5yr expected)
3.00
Price/Sales (ttm)
1.61
Price/Book (mrq)
2.23
Enterprise Value/Revenue
2.01
Enterprise Value/EBITDA
15.50
Financial Highlights
Profitability and Income Statement
Profit Margin
4.73%
Return on Assets (ttm)
4.04%
Return on Equity (ttm)
6.46%
Revenue (ttm)
664.43M
Net Income Avi to Common (ttm)
27.73M
Diluted EPS (ttm)
1.84
Balance Sheet and Cash Flow
Total Cash (mrq)
43.11M
Total Debt/Equity (mrq)
38.89%
Levered Free Cash Flow (ttm)
46.1M